Cargando…

Severe Candida infections in critically ill patients with COVID-19

The frequency of co-infections with bacterial or fungal pathogens has constantly increased among critically ill patients with coronavirus disease 2019 (COVID-19) during the pandemic. Candidemia was the most frequently reported invasive fungal co-infection. The onset of candidemia in COVID-19 patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koulenti, Despoina, Karvouniaris, Marios, Paramythiotou, Elisabeth, Koliakos, Nikolaos, Markou, Nikolaos, Paranos, Paschalis, Meletiadis, Joseph, Blot, Stijn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658040/ https://www.ncbi.nlm.nih.gov/pubmed/38028641 http://dx.doi.org/10.1016/j.jointm.2023.07.005

Ejemplares similares

Novel Antimicrobial Agents for Gram-Negative Pathogens
por: Karvouniaris, Marios, et al.
Publicado: (2023)

What’s new in invasive pulmonary aspergillosis in the critically ill
por: Koulenti, Despoina, et al.
Publicado: (2014)

Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using In Silico Modelling
por: Paranos, Paschalis, et al.
Publicado: (2022)

Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital
por: Paramythiotou, Elisabeth, et al.
Publicado: (2021)

Clinical Sepsis Phenotypes in Critically Ill Patients
por: Papathanakos, Georgios, et al.
Publicado: (2023)

Current Perspectives on the Diagnosis and Management of Healthcare-Associated Ventriculitis and Meningitis
por: Karvouniaris, Marios, et al.
Publicado: (2022)

Evaluating rates of ventilator-associated pneumonia: Consider patient, organizational & educational risk factors
por: Koulenti, Despoina, et al.
Publicado: (2017)

The value of polyurethane-cuffed endotracheal tubes to reduce microaspiration and intubation-related pneumonia: a systematic review of laboratory and clinical studies
por: Blot, Stijn I., et al.
Publicado: (2016)

Acinetobacter baumannii Bloodstream Infections in the COVID-19 Era: A Comparative Analysis between COVID-19 and Non-COVID-19 Critically Ill Patients
por: Andrianopoulos, Ioannis, et al.
Publicado: (2023)

Risk Factors for the First Episode of Klebsiella pneumoniae Resistant to Carbapenems Infection in Critically Ill Patients: A Prospective Study
por: Mantzarlis, Konstantinos, et al.
Publicado: (2013)

Epidemiology of Candidemia and Fluconazole Resistance in an ICU before and during the COVID-19 Pandemic Era
por: Routsi, Christina, et al.
Publicado: (2022)

Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients
por: Papathanakos, Georgios, et al.
Publicado: (2020)

Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study
por: Blot, Stijn, et al.
Publicado: (2014)

Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project
por: Blot, Stijn, et al.
Publicado: (2019)

Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin
por: Mpakosi, Alexandra, et al.
Publicado: (2016)

Candida endophthalmitis: A critical diagnosis in the critically ill
por: Au, L, et al.
Publicado: (2007)

Yeast central nervous system infection in a critically ill patient: a case report
por: Frantzeskaki, Frantzeska, et al.
Publicado: (2014)

Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates
por: Georgiou, Panagiota-Christina, et al.
Publicado: (2022)

Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy?
por: Dimopoulos, George, et al.
Publicado: (2023)

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
por: Markou, Nikolaos, et al.
Publicado: (2003)

806. Candida Gut Colonization in Critically Ill Patients
por: Adelman, Max W, et al.
Publicado: (2023)

Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients
por: Vandewoude, Koenraad H, et al.
Publicado: (2006)

Prevalence of skin pressure injury in critical care patients in the UK: results of a single-day point prevalence evaluation in adult critically ill patients
por: Rubulotta, Francesca, et al.
Publicado: (2022)

Risk factors for Candida colonization/infection in non-neutropenic medical critically ill patients
por: Nolla, J, et al.
Publicado: (2001)

Therapeutic variability in the treatment of Candida colonization/infection in non-neutropenic critically ill patients
por: León, C, et al.
Publicado: (2001)

Coagulation disorders and the role of tissue factor and tissue factor pathway inhibitor in critically ill patients
por: Frantzeskaki, F, et al.
Publicado: (2015)

Prevalence of candidemia and associated candida subtypes following severe sepsis in non-neutropenic critically ill patients
por: Kashiha, Arefeh, et al.
Publicado: (2018)

Candida glabrata candidemia: An emerging threat in critically ill patients
por: Gupta, Ashish, et al.
Publicado: (2015)

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2013)

Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection
por: Vassiliadi, Dimitra Argyro, et al.
Publicado: (2021)

Blood transfusions: an independent risk factor for the development of Candida infections in critically ill surgical patients
por: Burghi, G, et al.
Publicado: (2011)

Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later
por: Eggimann, Philippe, et al.
Publicado: (2014)

Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

An international survey on aminoglycoside practices in critically ill patients: the AMINO III study
por: Roger, Claire, et al.
Publicado: (2021)

Severe mediastinitis caused by an infected bronchogenic cyst
por: Koliakos, Evangelos, et al.
Publicado: (2023)

Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients
por: Maseda, Emilio, et al.
Publicado: (2018)

Neuropsychological Outcome of Critically Ill Patients with Severe Infection
por: Della Giovampaola, Maria, et al.
Publicado: (2022)

Comments on “Candida glabrata candidemia; an emerging threat in critically ill patients”
por: Ahmed, Armin, et al.
Publicado: (2015)

Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis
por: Thomas-Rüddel, Daniel O., et al.
Publicado: (2022)

In Vitro–In Vivo Correlation of Posaconazole–Amphotericin B Combination against Candida albicans: In Vitro Interacting Concentrations Are Associated with In Vivo Free Drug Levels
por: Meletiadis, Joseph, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7tu5ubb6chqs1vu5jn0qs2j0n6